- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 4th, 2007
Last month, when Harris & Harris (Nasdaq: TINY) was trading around $14.60 a share, I reminded readers that the payoff from an investment in this venture capital firm -- which specializes in nanotechnology -- would require a dose of patience, because the market for high-tech IPOs could remain tepid for the foreseeable future. Partly as a result of this reality, the stock has drifted lower.
Yesterday, though, Harris & Harris' stock plunged 12%, and it is now trading at just less than $12 a share. This latest drop, however, has nothing to do with the broader market and appears to be a gross overreaction to news earlier in the week that the company's president, Doug Jamison, was exercising some additional stock options.
|Related News Press|
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Imaging where cancer drugs go in the body could improve treatment October 26th, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016